Skip to content

A research comparing the height of the bone after implant placement in sinus augmented Maxilla on both sides with comparisons of blood clot and Platelet Rich Fibrin

Comparative evaluation of clinical and radiographic outcomes of simultaneously placed implant in sinus augmented ridges with blood clot alone versus Platelet Rich Fibrin (PRF): A split mouth randomized clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056786
Enrollment
8
Registered
2023-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Maxillary sinus augmentation with blood clot alone with immediate implant placement: Probing depth, Vertical bone gain, Bone density is measured at 0, 6, 9 month Control Intervention1:

Sponsors

Bathri Elangovan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient aged more than 18 years. Patient with severe atrophy of the posterior maxilla with 4-6 mm of residual bone height. Patient with a need for implant therapy in the bilateral posterior maxillary region. Patient coming under the category of ASA I. Patient with pathology-free sinus. Patient being without active periodontal diseases.

Exclusion criteria

Exclusion criteria: Patient with systemic disease/condition that might interfere with implant placement. Patient with active periodontal infection. Patient with history of parafunctional habits. Patient with habit of chronic smoking Patient with habit of chronic alcoholics. Patient undergoing corticosteroid therapy, chemotherapy, radiotherapy. Pregnant females. Patient with lack of stable posterior occlusion. Patient with a history of maxillary sinus pathologic features and/or surgery. Patient coming under the category of ASA II, III, IV

Design outcomes

Primary

MeasureTime frame
Researcher will come to know whether blood clot alone provides better bone gain when compared with Platelet Rich Fibrin (PRF) after maxillary sinus augmentation with simultaneous implant placement.Timepoint: 6, 9 month

Secondary

MeasureTime frame
Researcher will come to know whether blood clot alone provides better bone density when compared with Platelet Rich Fibrin (PRF) after maxillary sinus augmentation with simultaneous implant placement.Timepoint: 6, 9 month

Countries

India

Contacts

Public ContactDr. Biswajit Mishra

Government Dental College, Raipur

mishra.biswajit08@gmail.com9893095190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026